‘Significant movement' on Russia's request for phase-3 trial, manufacture of Sputnik V in India

Dr V K Paul, Member (Health) Niti Aayog, who also chairs the national expert group on COVID-19 vaccine administration, said that Indian scientists have looked at the data on Sputnik V, which is in the public domain now, and there would be a need for the phase -3 trial.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news